Personas / Equipo Humano

Marçal Pastor-Anglada

Buscador de publicaciones

Publicaciones

  • Minuesa G, Huber-Ruano I, Pastor-Anglada M, Koepsell H, Clotet B and Martinez-Picado J.

    Drug uptake transporters in antiretroviral therapy.

    PHARMACOL THERAPEUT . 132(3): 268-279. Nº de citas: 62

    [doi:10.1016/j.pharmthera.2011.06.007]

  • Fernández-Calotti PX, Colomer D and Pastor-Anglada M.

    Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 30(12): 1324-1340. Nº de citas: 14

    [doi:10.1080/15257770.2011.597372]

  • Errasti-Murugarren E, ESTHER PATRICIA DIAZ GONZALEZ, Godoy V, Riquelme G and Pastor-Anglada M.

    Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast.

    MOLECULAR PHARMACOLOGY . 80(5): 809-817. Nº de citas: 24

    [doi:10.1124/mol.111.071837]

  • Domingo P, Torres-Torronteras J, Pomar V, Giralt M, Domingo JC, Gutierrez Mdel M, Gallego-Escuredo JM, Mateo MG, Cano-Soldado P, Fernandez I, Pastor-Anglada M, Vidal F, Villarroya-Gombau F, Andreu A and Marti R.

    Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.

    PLoS One . 5(11): . Nº de citas: 11

    [doi:10.1371/journal.pone.0013896]

  • Errasti-Murugarren E, Casado FJ and Pastor-Anglada M.

    Different N-terminal motifs determine plasma membrane targeting of the human concentrative nucleoside transporter 3 in polarized and nonpolarized cells.

    MOLECULAR PHARMACOLOGY . 78(5): 795-803. Nº de citas: 14

    [doi:10.1124/mol.110.065920]

  • Huber-Ruano I, Pinilla-Macua I, Torres G, Casado FJ and Pastor-Anglada M.

    Link between high-affinity adenosine concentrative nucleoside transporter-2 (CNT2) and energy metabolism in intestinal and liver parenchymal cells.

    J CELL PHYSIOL . 225(2): 620-630. Nº de citas: 18

    [doi:10.1002/jcp.22254]

  • Gorraitz E, Pastor-Anglada M and Lostao MP.

    Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3).

    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY . 460(3): 617-632. Nº de citas: 7

    [doi:10.1007/s00424-010-0846-9]

  • Errasti-Murugarren E, Molina-Arcas M, Casado FJ and Pastor-Anglada M.

    The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.

    MOLECULAR PHARMACOLOGY . 78(2): 157-165. Nº de citas: 17

    [doi:10.1124/mol.110.063552]

  • Errasti-Murugarren E and Pastor-Anglada M.

    Drug transporter pharmacogenetics in nucleoside-based therapies.

    Pharmacogenomics . 11(6): 809-841. Nº de citas: 45

    [doi:10.2217/pgs.10.70]

  • Molina-Arcas M and Pastor-Anglada M.

    Role of nucleoside transporters in nucleoside-derived drug sensitivity.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 29(4-6): 335-346. Nº de citas: 10

    [doi:10.1080/15257771003729823]